Novel Repressive Roles of Estrogen Receptor β in Aggressive Breast Cancer
Episode Summary
Research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread, opening doors to targeted therapies and improved outcomes for patients with this aggressive disease.